These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7965271)

  • 21. [Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention].
    Ceconi C; Mastrorilli F; Squasi PA; Gaitani S; Guardigli G; Ferrari R
    Ital Heart J; 2005 Nov; 6 Suppl 7():5S-13S. PubMed ID: 16485512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ace-inhibitors and experimental atherosclerosis.
    Ambrosioni E; Bacchelli S; Degli Esposti D; Borghi C
    Clin Exp Hypertens; 1993; 15 Suppl 1():157-72. PubMed ID: 8513307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renin-angiotensin system modulation: the weight of evidence.
    Brown B; Hall AS
    Am J Hypertens; 2005 Sep; 18(9 Pt 2):127S-133S. PubMed ID: 16125049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin converting enzyme inhibition and coronary artery disease.
    Pepine CJ
    J Hypertens Suppl; 1994 Jul; 12(4):S65-71. PubMed ID: 7965277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The integrated effects of angiotensin II.
    Cody RJ
    Am J Cardiol; 1997 Mar; 79(5A):9-11. PubMed ID: 9127615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin as local modulating factor in ventricular dysfunction and failure due to coronary artery disease.
    Dzau VJ; Pratt R; Gibbons GH
    Drugs; 1994; 47 Suppl 4():1-13. PubMed ID: 7523057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vascular remodeling and angiotensin II].
    Takemoto M; Egashira K
    Nihon Rinsho; 1999 May; 57(5):1158-63. PubMed ID: 10361450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin II and cell cycle regulation.
    Wolf G; Wenzel UO
    Hypertension; 2004 Apr; 43(4):693-8. PubMed ID: 14967829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin converting enzyme inhibitors: inhibition of growth, a novel mechanism of action.
    Fish AF
    J Cardiovasc Nurs; 1994 Jul; 8(4):57-71. PubMed ID: 7931465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ventricular remodeling.
    Maisch B
    Cardiology; 1996; 87 Suppl 1():2-10. PubMed ID: 8681317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin II and coronary artery disease, congestive heart failure, and sudden cardiac death.
    Dietz R; von Harsdorf R; Gross M; Krämer J; Gulba D; Willenbrock R; Osterziel KJ
    Basic Res Cardiol; 1998; 93 Suppl 2():101-8. PubMed ID: 9833171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural changes in cardiovascular disease.
    Cohn JN
    Am J Cardiol; 1995 Nov; 76(15):34E-37E. PubMed ID: 7484886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential Antithrombotic and Fibrinolytic Properties of the Angiotensin Converting Enzyme Inhibitors.
    Ridker PM; Vaughan DE
    J Thromb Thrombolysis; 1995; 1(3):251-257. PubMed ID: 10608002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of mechanical and humoral factors in growth regulation of vascular smooth muscle and cardiac myocytes.
    Dzau VJ
    Curr Opin Nephrol Hypertens; 1993 Jan; 2(1):27-32. PubMed ID: 7922163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacology of cardiac and vascular remodeling.
    Struijker-Boudier HA; Smits JF; De Mey JG
    Annu Rev Pharmacol Toxicol; 1995; 35():509-39. PubMed ID: 7598505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin and the Heart. Symposium proceedings. Hamburg, October 22-24, 1992.
    Basic Res Cardiol; 1993; 88 Suppl 1():1-222. PubMed ID: 8102846
    [No Abstract]   [Full Text] [Related]  

  • 37. [Vasoactive substances and growth].
    Z Kardiol; 1992 Mar; 81(3):182-4. PubMed ID: 1533981
    [No Abstract]   [Full Text] [Related]  

  • 38. Do ACE inhibitors improve insulin sensitivity?
    Petrie JR; Morris AD; Ueda S; Elliott HL; Connell JM; Small M; Donnelly R
    Lancet; 1995 Aug; 346(8974):583-4. PubMed ID: 7658810
    [No Abstract]   [Full Text] [Related]  

  • 39. Perspective in progress of cardiovascular gene therapy.
    Morishita R
    J Pharmacol Sci; 2004 May; 95(1):1-8. PubMed ID: 15153644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetics and molecular biology.
    Morgan R
    Curr Opin Lipidol; 1995 Aug; 6(4):U89-92. PubMed ID: 7670746
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.